You are here

Article Text

Article menu
Download PDFPDF
Ophthalmology
Cystoid macular oedema: a rare complication following selective laser trabeculoplasty
  1. James Richardson-May1,2,
  2. William Evans3,
  3. Shweta Pandey2 and
  4. Karinya Lewis4
  1. 1Ophthalmology, University Hospital Southampton NHS Foundation Trust, Southampton, UK
  2. 2Ophthalmology, Salisbury District Hospital NHS Foundation Trust, Salisbury, UK
  3. 3Salisbury District Hospital NHS Foundation Trust, Salisbury, UK
  4. 4Ophthalmology, Salisbury District Hospital, Salisbury, UK
  1. Correspondence to Dr James Richardson-May; jamesrichardsonmay{at}gmail.com

Abstract

A female patient with previous vitrectomy for epiretinal membrane in the left eye underwent bilateral selective laser trabeculoplasty (SLT) for pigmentary glaucoma and subsequently developed cystoid macular oedema (CMO) in the vitrectomised eye. This resolved fully with treatment with topical steroids and non-steroidal anti-inflammatory drug (NSAID) drops. This complication has been very rarely reported in the literature, and a subsequent internal audit found a very low rate of CMO temporally related to SLT of 0.07%. We suggest close follow-up and ‘red flag’ follow-up instructions to patients with previous vitrectomy or epiretinal membrane to watch for this complication, and clinicians may consider covering higher risk patients with an NSAID post-laser.

  • Glaucoma
  • Retina

https://doi.org/10.1136/bcr-2024-262307

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Contributors The following authors were responsible for drafting of the text, sourcing and editing of clinical images, investigation results, drawing original diagrams and algorithms and critical revision for important intellectual content: JR-M, WE, SP and KAL. The following author gave final approval of the manuscript: KAL. JR-M is the guarantor for the manuscript.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Case reports provide a valuable learning resource for the scientific community and can indicate areas of interest for future research. They should not be used in isolation to guide treatment choices or public health policy.

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; externally peer reviewed.